What is ACADIA Pharmaceuticals Inc (ACAD)?
ACADIA Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of innovative medicines for central nervous system disorders. The company focuses on conditions such as Parkinson's disease psychosis, schizophrenia, and other neurological and psychiatric disorders. ACADIA's research efforts include the discovery and development of novel compounds targeting specific receptors and pathways involved in brain function. The company collaborates with academic institutions and industry partners to advance its clinical programs. It maintains a portfolio of approved therapies as well as investigational drugs in various stages of development. ACADIA Pharmaceuticals operates with an emphasis on addressing unmet medical needs in neuropharmacology.
ACADIA Pharmaceuticals Inc Stock Price Today: Live Overview
The price today is shaped by live trading activity with ACADIA Pharmaceuticals Inc currently at $21.02. The session has seen price movement between $20.24 and $21.02, reflecting a daily change of +0.0478%.
FAQ: ACADIA Pharmaceuticals Inc (ACAD)
What is the current price of ACAD stock?
ACADIA Pharmaceuticals Inc closed at $21.02 today.
Does ACAD pay dividends?
ACADIA Pharmaceuticals Inc does not pay dividends.
Does ACAD have a formal corporate presence or regional headquarters in the UAE?
ACADIA Pharmaceuticals Inc operates in the UAE through partners and distributors without an official office.
What is ACAD best known for?
ACADIA Pharmaceuticals Inc is most famous for developing treatments for central nervous system disorders.
What assets are typically shown together with ACAD?
Commonly shown alongside ACAD: Mondelez, JB Hi-Fi Limited, National Grid
Latest shares articles



